PS229
Circulating EVs for AML minimal residual disease biomarkers detection
1 Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; ICBAS-UP – Institute of Biomedical Sciences Abel Salazar of the University of Porto, Portugal
2 Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal
3 Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; FMUP – Faculty of Medicine of the University of Porto, Portugal; HSJ – Hospital de São João, Porto, Portugal
4 Cancer Drug Resistance Group, IPATIMUP – Institute of Molecular Pathology and Immunology of the University of Porto, Portugal; i3S – Instituto de Investigação e Inovação em Saúde, University of Porto, Portugal; FFUP – Faculty of Pharmacy of the University of Porto, Portugal
Read
2574
Timeswas read the article
716
Total PDF
1858
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 7 | 3 | 10 |
| 2025 11 | 19 | 20 | 39 |
| 2025 10 | 14 | 11 | 25 |
| 2025 9 | 19 | 9 | 28 |
| 2025 8 | 15 | 10 | 25 |
| 2025 7 | 22 | 7 | 29 |
| 2025 6 | 33 | 9 | 42 |
| 2025 5 | 20 | 5 | 25 |
| 2025 4 | 38 | 1 | 39 |
| 2025 3 | 26 | 5 | 31 |
| 2025 2 | 27 | 1 | 28 |
| 2025 1 | 25 | 6 | 31 |
| 2024 12 | 17 | 3 | 20 |
| 2024 11 | 30 | 2 | 32 |
| 2024 10 | 12 | 3 | 15 |
| 2024 9 | 22 | 8 | 30 |
| 2024 8 | 22 | 8 | 30 |
| 2024 7 | 9 | 5 | 14 |
| 2024 6 | 10 | 4 | 14 |
| 2024 5 | 12 | 4 | 16 |
| 2024 4 | 15 | 6 | 21 |
| 2024 3 | 15 | 3 | 18 |
| 2024 2 | 9 | 5 | 14 |
| 2024 1 | 14 | 8 | 22 |
| 2023 12 | 8 | 5 | 13 |
| 2023 11 | 9 | 2 | 11 |
| 2023 10 | 13 | 6 | 19 |
| 2023 9 | 6 | 2 | 8 |
| 2023 8 | 16 | 2 | 18 |
| 2023 7 | 8 | 5 | 13 |
| 2023 6 | 15 | 7 | 22 |
| 2023 5 | 45 | 1 | 46 |
| 2023 4 | 26 | 2 | 28 |
| 2023 3 | 18 | 3 | 21 |
| 2023 2 | 9 | 3 | 12 |
| 2023 1 | 9 | 4 | 13 |
| 2022 12 | 11 | 8 | 19 |
| 2022 11 | 12 | 6 | 18 |
| 2022 10 | 12 | 7 | 19 |
| 2022 9 | 9 | 9 | 18 |
| 2022 8 | 8 | 7 | 15 |
| 2022 7 | 9 | 4 | 13 |
| 2022 6 | 9 | 5 | 14 |
| 2022 5 | 10 | 16 | 26 |
| 2022 4 | 15 | 13 | 28 |
| 2022 3 | 14 | 8 | 22 |
| 2022 2 | 9 | 4 | 13 |
| 2022 1 | 13 | 6 | 19 |
| 2021 12 | 14 | 12 | 26 |
| 2021 11 | 13 | 9 | 22 |
| 2021 10 | 14 | 10 | 24 |
| 2021 9 | 16 | 12 | 28 |
| 2021 8 | 4 | 6 | 10 |
| 2021 7 | 9 | 4 | 13 |
| 2021 6 | 18 | 8 | 26 |
| 2021 5 | 11 | 5 | 16 |
| 2021 4 | 48 | 9 | 57 |
| 2021 3 | 11 | 10 | 21 |
| 2021 2 | 13 | 5 | 18 |
| 2021 1 | 8 | 12 | 20 |
| 2020 12 | 12 | 10 | 22 |
| 2020 11 | 21 | 9 | 30 |
| 2020 10 | 10 | 11 | 21 |
| 2020 9 | 15 | 10 | 25 |
| 2020 8 | 14 | 7 | 21 |
| 2020 7 | 11 | 8 | 19 |
| 2020 6 | 18 | 2 | 20 |
| 2020 5 | 16 | 8 | 24 |
| 2020 4 | 16 | 6 | 22 |
| 2020 3 | 24 | 1 | 25 |
| 2020 2 | 23 | 8 | 31 |
| 2020 1 | 27 | 8 | 35 |
| 2019 12 | 37 | 9 | 46 |
| 2019 11 | 17 | 9 | 26 |
| 2019 10 | 23 | 2 | 25 |
| 2019 9 | 23 | 7 | 30 |
| 2019 8 | 25 | 4 | 29 |
| 2019 7 | 13 | 4 | 17 |
| 2019 6 | 36 | 10 | 46 |
| 2019 5 | 50 | 23 | 73 |
| 2019 4 | 32 | 2 | 34 |
| 2019 3 | 39 | 2 | 41 |
| 2019 2 | 30 | 7 | 37 |
| 2019 1 | 28 | 2 | 30 |
| 2018 12 | 23 | 2 | 25 |
| 2018 11 | 14 | 0 | 14 |
| 2018 10 | 15 | 12 | 27 |
| 2018 9 | 9 | 0 | 9 |
| 2018 8 | 14 | 9 | 23 |
| 2018 7 | 27 | 11 | 38 |
| 2018 6 | 25 | 11 | 36 |
| 2018 5 | 29 | 11 | 40 |
| 2018 4 | 33 | 11 | 44 |
| 2018 3 | 53 | 10 | 63 |
| 2018 2 | 36 | 19 | 55 |
| 2018 1 | 10 | 14 | 24 |
| 2017 12 | 21 | 15 | 36 |
| 2017 11 | 14 | 12 | 26 |
| 2017 10 | 19 | 16 | 35 |
| 2017 9 | 12 | 11 | 23 |
Show all